We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00907309
First Posted: May 22, 2009
Last Update Posted: October 7, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Cambridge Health Alliance
Tufts Medical Center
Harvard School of Dental Medicine
Fallon Clinic
Information provided by (Responsible Party):
John R Knight, MD, Boston Children's Hospital
May 20, 2009
May 22, 2009
October 7, 2016
September 2010
September 2012   (Final data collection date for primary outcome measure)
Frequency of tobacco, alcohol, marijuana, and other drug use [ Time Frame: 3 months, 6 months ]
Same as current
Complete list of historical versions of study NCT00907309 on ClinicalTrials.gov Archive Site
Rates of initiation and cessation of tobacco, alcohol, marijuana and other drug use [ Time Frame: 3 months, 6 months ]
Same as current
Not Provided
Not Provided
 
Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use
Dental and Medical Office Internet/Intranet Motivational Enhancement Therapy to Reduce Teen Tobacco, Alcohol, and Drug Use
The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.
We have previously developed and tested in a treatment population a promising MET program for alcohol and drug use. We will broaden the MET intervention to also target tobacco use and convert the new materials into a self-administered format.
Interventional
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Use; Tobacco, Harmful
  • Alcohol Abuse
  • Drug Abuse
  • Behavioral: iMET
    Participants will receive the iMET intervention
  • Behavioral: iMET/TE
    Participants will receive the iMET intervention and also receive TEs (Technological Extenders)
  • No Intervention: Treatment as usual
    Participants will receive treatment as usual from their provider.
  • Experimental: iMET
    Participants will receive the iMET intervention.
    Intervention: Behavioral: iMET
  • Experimental: iMET/TE
    Participants will receive the iMET intervention and Technological Extenders (TEs).
    Intervention: Behavioral: iMET/TE
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
121
September 2012
September 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 12-21 years old
  • Coming for routine care

Exclusion Criteria:

  • Medically or emotionally unstable day of visit
  • Already receiving behavioral health services
  • Cannot read/understand English
  • Will not be available for post-tests
Sexes Eligible for Study: All
12 Years to 21 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00907309
iMET RFA-OD-09-003
Yes
Not Provided
Not Provided
John R Knight, MD, Boston Children's Hospital
Boston Children’s Hospital
  • Cambridge Health Alliance
  • Tufts Medical Center
  • Harvard School of Dental Medicine
  • Fallon Clinic
Principal Investigator: John R. Knight, MD Boston Children’s Hospital
Boston Children’s Hospital
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP